Ad
related to: deletion 18q syndrome prognosis stage 0 lung cancer treatment medicine- Clinical Trials
Find Info on Clinical Trials
For this Treatment Option.
- Dosing Information
Learn About Dosing Schedules
For this Treatment Option.
- FAQs
Find FAQs for This
Treatment On The Official Site.
- Caregiver Support
Find Resources for Caregivers
at the Official Site Today.
- Clinical Trials
Search results
Results from the WOW.Com Content Network
Specialty. Medical genetics. Distal 18q- is a genetic condition caused by a deletion of genetic material within one of the two copies of chromosome 18. [1] The deletion involves the distal section of 18q and typically extends to the tip of the long arm of chromosome 18. [2]
Proximal 18q-is a rare genetic condition caused by a deletion of genetic material within one of the two copies of chromosome 18. This deletion involves the proximal (near the centromere ) section of the long arm of chromosome 18 somewhere between 18q11.2 (18.9 Mb) to 18q21.1 (43.8 Mb). [1]
18p-. 18p-, also known as monosomy 18p, deletion 18p syndrome, del (18p) syndrome, partial monosomy 18p, or de Grouchy syndrome 1, is a genetic condition caused by a deletion of all or part of the short arm (the p arm) of chromosome 18. It occurs in about 1 of every 50,000 births. [ 1 ]
Lung cancer staging is the assessment of the extent to which a lung cancer has spread from its original source. As with most cancers, staging is an important determinant of treatment and prognosis. In general, more advanced stages of cancer are less amenable to treatment and have a worse prognosis. The initial evaluation of non-small cell lung ...
Rare. Undifferentiated pleomorphic sarcoma ( UPS ), also termed pleomorphic myofibrosarcoma, [ 1] high-grade myofibroblastic sarcoma, and high-grade myofibrosarcoma, [ 2] is characterized by the World Health Organization (WHO) as a rare, poorly differentiated neoplasm (i.e., an abnormal growth of cells that have an unclear identity and/or cell ...
Lung cancer. Lung cancer, also known as lung carcinoma, is a malignant tumor that begins in the lung. Lung cancer is caused by genetic damage to the DNA of cells in the airways, often caused by cigarette smoking or inhaling damaging chemicals. Damaged airway cells gain the ability to multiply unchecked, causing the growth of a tumor.
For example, the blockbuster drug Avastin was originally approved to treat colorectal cancer in 2004, but then later approved as a lung cancer treatment in 2006 and brain and kidney cancer ...
Oncology. Non-small-cell lung cancer ( NSCLC ), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [ 1][ 2][ 3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.
Ad
related to: deletion 18q syndrome prognosis stage 0 lung cancer treatment medicine